FDA Inspection 1254614 — Vitalant Reference and Transfusion Service

Vitalant Reference and Transfusion Service — FEI 3010702264

The FDA completed an inspection of Vitalant Reference and Transfusion Service on November 14, 2024 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 14, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Chicago, IL (United States)